pentobarbital will decrease the level or outcome of diazepam intranasal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Robust or moderate CYP3A4 inducers may possibly maximize rate of diazepam elimination; thus, efficacy of diazepam could be reduced.
pentobarbital will decrease the level or result of meloxicam by influencing hepatic enzyme CYP2C9/10 metabolism. Slight/Importance Not known.
Keep track of Intently (1)pentobarbital will reduce the extent or influence of levamlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will decrease the extent or result of phenytoin by affecting hepatic enzyme CYP2C9/ten metabolism. Use Caution/Watch.
pentobarbital will lessen the extent or effect of bedaquiline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Prevent coadministration of bedaquiline with sturdy CYP3A4 inducers as a consequence of likely for diminished therapeutic result
Contraindicated (one)pentobarbital will lower the extent or result of dienogest/estradiol valerate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Girls must not pick estradiol valerate/dienogest as their contraceptive while making use of robust CYP3A4 inducers as a consequence of possible lessen in contraceptive efficacy.
pentobarbital will decrease the level or result of roflumilast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not recommended; powerful cytochrome P450 enzyme inducers reduce systemic publicity to roflumilast and could lessen the therapeutic success
pentobarbital will reduce the extent or influence of montelukast by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
Stay clear of; coadministration with CYP3A inducers may lead to lessened plasma concentrations of elvitegravir and/or even a concomitantly administered protease inhibitor and bring on lack of therapeutic outcome also to attainable resistance
pentobarbital will reduce the extent or influence of diazepam buccal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Potent or average CYP3A4 inducers may well increase charge of diazepam elimination; as a result, efficacy of diazepam may be lessened.
Drugs that have amount website boundaries related with Every single prescription. This restriction generally restrictions the quantity of your drug that could be covered.
pentobarbital will decrease the level or impact of atorvastatin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch.
pentobarbital will lower the extent or outcome of etravirine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will lessen the level or impact of nitrendipine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Not known.